PTSD by the Numbers

,
Cannabis Patient Care, December 2021, Volume 2, Issue 4
Pages: 8

Tetragram shares some anonymous user data to see a snapshot of real-world results for patients reporting symptoms of PTSD.

Gathering real world data for medical cannabis patients is challenging, but the potential benefits to fellow patients could be outstanding. Tetragram, founded by Otha Smith, is a mobile app that allows users to anonymously track cannabis products enabling them to find the best products that suit their needs. Here, Tetragam shares some of the most recent data tied to patients reporting symptom management for post-traumatic stress disorder (PTSD) to see what type of products patients are finding useful, how they are consuming it, and more.

Patients that selected PTSD for as their primary symptom equaled 125 sessions. Of those sessions, 21.35 reported tetrahydrocannabinol (THC), 7.5 reported tetrahydrocannabinolic acid (THCA), 1.7 reported cannabidiol (CBD), 0.81 reported cannabidiolic acid (CBDA), 0.04 reported tetrahydrocannabivarin (THCV), and 0.03 reported cannabidivarin (CBDV) in their product.